FDA Releases Draft Guidance on Human Gene Therapy IND Submissions

Summary

The Food and Drug Administration (FDA) has made available a draft document outlining the content and review of Chemistry, Manufacturing, and Control (CMC) information for human gene therapy Investigational New Drug Applications (INDs), aimed at providing guidance for FDA review staff and sponsors on IND submissions and CMC review processes.